Features of angiotensin-converting enzyme inhibitors pharmacoepidemiology on the example of the regional pharmaceutical market

Arterial hypertension is a widespread epidemic worldwide and one of the most common risk factors for stroke, myocardial infarction, heart failure and other cardiovascular diseases. One of the leading drugs groups in the treatment of hypertension is rightfully angiotensin converting enzyme (ACE) inhibitors. The study evaluated the pharmacoepidemiology of angiotensin converting enzyme inhibitors on the example of the regional pharmaceutical market.